Tokyo, Dec. 31 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060231) titled 'Effects of Weekly Injection of Semaglutide on Vascular Endothelial Function in Japanese Patients with Type-2 Diabetes, A Retrospective Study' on Dec. 31.
Study Type:
Observational
Primary Sponsor:
Institute - Jinnouchi Hospital
Condition:
Condition - Japanese patients with type-2 diabetes
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - We examined the effects of weekly injection of Semaglutide on Vascular endothelial function in Japanese patients with type-2 DM.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
=
Gender - Male and Female
Key inclusion criteria - Patients admitted to Jinnouchi Hospital.
Patients were examined endothelial function by RH-PAT.
Semaglutide therapy was started during the hospitalization.
Key exclusion criteria - None
Target Size - 24
Recruitment Status:
Recruitment status - Completed
Date of protocol fixation - 2021 Year 01 Month 01 Day
Date of IRB - 2025 Year 06 Month 30 Day
Anticipated trial start date - 2021 Year 01 Month 01 Day
Last follow-up date - 2025 Year 11 Month 02 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068149
Disclaimer: Curated by HT Syndication.
